RNS Number : 4005X
Ilika plc
26 April 2023
 

Ilika plc

("Ilika" or the "Company")

 

Exercise of Options and Total Voting Rights

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology announces that on 21 April 2023, following the vesting of options under the Company's EMI share option schemes, 5,750 options with an exercise price of 21p, together with 210,000 options with an exercise price of 18.2p, and a further 375,000 options with an exercise price of 25.5p have been converted into ordinary shares of one penny each in the Company ("Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for 590,750 Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 27 April 2023.

 

The options represent in aggregate 0.37 per cent of the Company's issued share capital.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 158,474,367 ordinary shares of one penny each and that number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury. 

 

 

 

For more information contact:


Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR







Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber,


William Hall, Nikhil Varghese






Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,


Mara Grasso






Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Lianne Applegarth

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

Tom Cooper

Mob: 07971 221 972

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKPBQKBKDKQB